In the Pharmaceuticals & Drugs sector, Parmax Pharma Ltd. significantly underperforms compared to its peers, showing no revenue growth or profitability metrics. Companies like Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. emerge as strong leaders with impressive growth rates and profitability, while Parmax Pharma remains financially weak, indicating a high-risk investment.

• • Parmax Pharma Ltd. shows no revenue growth, negative PE, and zero ROE, indicating financial weakness.
• • Sun Pharmaceutical Industries and Dr. Reddy's Laboratories are sector leaders in profitability and growth.
• • Companies with low valuation metrics like Cipla Ltd. are strong value picks despite higher PE ratios.